{"ticker": "ATHA", "overview": {"cik": "1620463", "ticker": "LONA", "name": "LeonaBio, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "SCHEDULE 13D/A", "date": "2026-10-28", "title": "Form SCHEDULE 13D/A", "accession": "0001655566-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-10-26", "title": "Insider transaction", "accession": "0001193125-26-431896", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2026-10-26", "title": "Form SCHEDULE 13D/A", "accession": "0001193125-26-431897", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-22", "title": "Material event", "accession": "0001193125-26-397952", "price_sensitive": true}, {"form": "3", "date": "2026-09-03", "title": "PRIMARY DOCUMENT", "accession": "0002126186-26-000001", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-08-31", "title": "Form SCHEDULE 13D", "accession": "0001655566-26-000003", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-26", "title": "Material event", "accession": "0001193125-26-368288", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-08-25", "title": "Form SCHEDULE 13D/A", "accession": "0001193125-26-365096", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-20", "title": "Form SCHEDULE 13G/A", "accession": "0001636587-26-000069", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "Quarterly report", "accession": "0001193125-26-352243", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-14", "title": "Material event", "accession": "0001193125-26-352208", "price_sensitive": true}, {"form": "4", "date": "2026-07-10", "title": "Insider transaction", "accession": "0001193125-26-300876", "price_sensitive": false}, {"form": "4", "date": "2026-07-09", "title": "Insider transaction", "accession": "0001193125-26-299927", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001843393-26-000006", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001580111-26-000010", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001790314-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001679039-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001722055-26-000005", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001164426-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001225501-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001763316-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001258693-26-000011", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-23", "title": "Material event", "accession": "0001193125-26-279425", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-05-15", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-062870", "price_sensitive": false}, {"form": "ARS", "date": "2026-05-11", "title": "Form ARS", "accession": "0001193125-26-217029", "price_sensitive": false}]}, "description": "ATHA trades as ATHA. Privy Trades holds 155 insider filings for the company, from September 2020 to January 2026. Across those, 15 insiders disclosed 16 open-market purchases totalling $62.12M against 35 sales totalling $229.82K. The most recent filing on record is dated 2 January 2026.", "exchange": null, "stats": {"buy_n": 16, "buy_sum": 62119770.981300004, "sell_n": 35, "sell_sum": 229821.94759999998, "net": 61889949.033700004, "insiders": 15, "first_date": "2020-09-18", "last_date": "2026-01-02"}, "metrics": {"ticker": "ATHA", "has_prices": false}, "trades": [{"id": "0001861464-26-000002", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark Worthington", "who_key": "Worthington Mark", "role": "General Counsel and CCO", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 6026.88, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $6K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000186146426000002/0001861464-26-000002-index.htm", "trade_date": "2026-01-02", "timestamp": "2026-01-02", "mins": 438644}, {"id": "0001822499-26-000002", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kevin Church", "who_key": "CHURCH KEVIN", "role": "CHIEF SCIENTIFIC OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 6026.88, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "An exit at the top? Exec sells $6K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000182249926000002/0001822499-26-000002-index.htm", "trade_date": "2026-01-02", "timestamp": "2026-01-02", "mins": 438644}, {"id": "0002037968-26-000002", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Robert Renninger", "who_key": "Renninger Robert", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 2043.36, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO sells $2K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000203796826000002/0002037968-26-000002-index.htm", "trade_date": "2026-01-02", "timestamp": "2026-01-02", "mins": 438644}, {"id": "0001604834-26-000002", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark James Litton", "who_key": "Litton Mark James", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 17791.68, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO offloads $18K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000160483426000002/0001604834-26-000002-index.htm", "trade_date": "2026-01-02", "timestamp": "2026-01-02", "mins": 438644}, {"id": "0001794629-26-000002", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Martin Javier San", "who_key": "San Martin Javier", "role": "CHIEF MEDICAL OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 11310.72, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite trims ATHA: $11K", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000179462926000002/0001794629-26-000002-index.htm", "trade_date": "2026-01-02", "timestamp": "2026-01-02", "mins": 438644}, {"id": "0001861464-25-000003", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark Worthington", "who_key": "Worthington Mark", "role": "General Counsel and CCO", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000186146425000003/0001861464-25-000003-index.htm", "trade_date": "2025-12-24", "timestamp": "2025-12-24", "mins": 451604}, {"id": "0001794629-25-000003", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Martin Javier San", "who_key": "San Martin Javier", "role": "CHIEF MEDICAL OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000179462925000003/0001794629-25-000003-index.htm", "trade_date": "2025-12-24", "timestamp": "2025-12-24", "mins": 451604}, {"id": "0001822499-25-000005", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kevin Church", "who_key": "CHURCH KEVIN", "role": "CHIEF SCIENTIFIC OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000182249925000005/0001822499-25-000005-index.htm", "trade_date": "2025-12-24", "timestamp": "2025-12-24", "mins": 451604}, {"id": "0001604834-25-000004", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark James Litton", "who_key": "Litton Mark James", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000160483425000004/0001604834-25-000004-index.htm", "trade_date": "2025-12-24", "timestamp": "2025-12-24", "mins": 451604}, {"id": "0002037968-25-000003", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Robert Renninger", "who_key": "Renninger Robert", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000203796825000003/0002037968-25-000003-index.htm", "trade_date": "2025-12-24", "timestamp": "2025-12-24", "mins": 451604}, {"id": "0001012975-25-000979", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Perceptive Advisors LLC", "who_key": "PERCEPTIVE ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 8375815.1, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000101297525000979/0001012975-25-000979-index.htm", "trade_date": "2025-12-23", "timestamp": "2025-12-23", "mins": 453044}, {"id": "0001415889-25-019064", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Robert Renninger", "who_key": "Renninger Robert", "role": "SVP, Finance and Accounting", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 850.2695, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Someone inside ATHA is selling \u2014 $850 worth", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925019064/0001415889-25-019064-index.htm", "trade_date": "2025-07-01", "timestamp": "2025-07-01", "mins": 705044}, {"id": "0001415889-25-019066", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark Worthington", "who_key": "Worthington Mark", "role": "General Counsel and CCO", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 2502.381, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $3K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925019066/0001415889-25-019066-index.htm", "trade_date": "2025-07-01", "timestamp": "2025-07-01", "mins": 705044}, {"id": "0001415889-25-019068", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Martin Javier San", "who_key": "San Martin Javier", "role": "CHIEF MEDICAL OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 3182.127, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Top exec sells $3K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925019068/0001415889-25-019068-index.htm", "trade_date": "2025-07-01", "timestamp": "2025-07-01", "mins": 705044}, {"id": "0001415889-25-019069", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark James Litton", "who_key": "Litton Mark James", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 7373.6005, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ATHA's CEO lightens up \u2014 $7K sold", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925019069/0001415889-25-019069-index.htm", "trade_date": "2025-07-01", "timestamp": "2025-07-01", "mins": 705044}, {"id": "0001415889-25-019070", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kevin Church", "who_key": "CHURCH KEVIN", "role": "CHIEF SCIENTIFIC OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 2502.381, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite trims ATHA: $3K", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925019070/0001415889-25-019070-index.htm", "trade_date": "2025-07-01", "timestamp": "2025-07-01", "mins": 705044}, {"id": "0001415889-25-015431", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Grant Pickering", "who_key": "PICKERING GRANT", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925015431/0001415889-25-015431-index.htm", "trade_date": "2025-05-30", "timestamp": "2025-05-30", "mins": 751124}, {"id": "0001415889-25-015434", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Barbara Kosacz", "who_key": "Kosacz Barbara", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925015434/0001415889-25-015434-index.htm", "trade_date": "2025-05-30", "timestamp": "2025-05-30", "mins": 751124}, {"id": "0001415889-25-015436", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "James A. Johnson", "who_key": "JOHNSON JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925015436/0001415889-25-015436-index.htm", "trade_date": "2025-05-30", "timestamp": "2025-05-30", "mins": 751124}, {"id": "0001415889-25-015438", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Joseph Edelman", "who_key": "EDELMAN JOSEPH", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925015438/0001415889-25-015438-index.htm", "trade_date": "2025-05-30", "timestamp": "2025-05-30", "mins": 751124}, {"id": "0001415889-25-015439", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kelly A. Romano", "who_key": "Romano Kelly A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925015439/0001415889-25-015439-index.htm", "trade_date": "2025-05-30", "timestamp": "2025-05-30", "mins": 751124}, {"id": "0001415889-25-015440", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Michael A. Panzara", "who_key": "Panzara Michael A.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925015440/0001415889-25-015440-index.htm", "trade_date": "2025-05-30", "timestamp": "2025-05-30", "mins": 751124}, {"id": "0001415889-25-015441", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "John M. Fluke Jr", "who_key": "FLUKE JOHN M JR", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925015441/0001415889-25-015441-index.htm", "trade_date": "2025-05-30", "timestamp": "2025-05-30", "mins": 751124}, {"id": "0001415889-25-006531", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark Worthington", "who_key": "Worthington Mark", "role": "General Counsel and CCO", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925006531/0001415889-25-006531-index.htm", "trade_date": "2025-03-03", "timestamp": "2025-03-03", "mins": 877844}, {"id": "0001415889-25-006534", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Martin Javier San", "who_key": "San Martin Javier", "role": "CHIEF MEDICAL OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925006534/0001415889-25-006534-index.htm", "trade_date": "2025-03-03", "timestamp": "2025-03-03", "mins": 877844}, {"id": "0001415889-25-006536", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark James Litton", "who_key": "Litton Mark James", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925006536/0001415889-25-006536-index.htm", "trade_date": "2025-03-03", "timestamp": "2025-03-03", "mins": 877844}, {"id": "0001415889-25-006552", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kevin Church", "who_key": "CHURCH KEVIN", "role": "CHIEF SCIENTIFIC OFFICER", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925006552/0001415889-25-006552-index.htm", "trade_date": "2025-03-03", "timestamp": "2025-03-03", "mins": 877844}, {"id": "0001415889-25-006553", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Robert Renninger", "who_key": "Renninger Robert", "role": "SVP, Finance and Accounting", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925006553/0001415889-25-006553-index.htm", "trade_date": "2025-03-03", "timestamp": "2025-03-03", "mins": 877844}, {"id": "0001415889-25-007858", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Robert Renninger", "who_key": "Renninger Robert", "role": "SVP, Finance and Accounting", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on ATHA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925007858/0001415889-25-007858-index.htm", "trade_date": "2025-03-03", "timestamp": "2025-03-03", "mins": 877844}, {"id": "0001415889-25-000525", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Mark Worthington", "who_key": "Worthington Mark", "role": "General Counsel and CCO", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 4781.768999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider trims $5K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925000525/0001415889-25-000525-index.htm", "trade_date": "2025-01-02", "timestamp": "2025-01-02", "mins": 964244}], "recent_buys": [{"id": "0001415889-24-018177", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kelly A. Romano", "who_key": "Romano Kelly A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 100050.72, "score": 46.8, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board insider adds $100K of ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924018177/0001415889-24-018177-index.htm", "trade_date": "2024-06-24", "timestamp": "2024-06-24", "mins": 1240724}, {"id": "0001062993-23-023291", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Perceptive Advisors LLC", "who_key": "PERCEPTIVE ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1462895.16, "score": 54.3, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ATHA lands a $1.5M vote of confidence from A board member", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000106299323023291/0001062993-23-023291-index.htm", "trade_date": "2023-12-29", "timestamp": "2023-12-29", "mins": 1497044}, {"id": "0001209191-23-035951", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Andrew Gengos", "who_key": "Gengos Andrew", "role": "See Below", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 51445.007699999995, "score": 33.2, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders now buying ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123035951/0001209191-23-035951-index.htm", "trade_date": "2023-06-07", "timestamp": "2023-06-07", "mins": 1792244}, {"id": "0001209191-23-034887", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Andrew Gengos", "who_key": "Gengos Andrew", "role": "See Below", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 191572.2136, "score": 48.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying ATHA \u2014 4 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123034887/0001209191-23-034887-index.htm", "trade_date": "2023-06-05", "timestamp": "2023-06-05", "mins": 1795124}, {"id": "0001209191-23-021878", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Grant Pickering", "who_key": "PICKERING GRANT", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 60350.0, "score": 51.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying ATHA \u2014 4 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123021878/0001209191-23-021878-index.htm", "trade_date": "2023-03-30", "timestamp": "2023-03-30", "mins": 1891604}, {"id": "0001209191-23-021708", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "James A. Johnson", "who_key": "JOHNSON JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 12000.0, "score": 28.4, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders now buying ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123021708/0001209191-23-021708-index.htm", "trade_date": "2023-03-29", "timestamp": "2023-03-29", "mins": 1893044}, {"id": "0001209191-22-063009", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Glenna Mileson", "who_key": "MILESON GLENNA", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 142250.0, "score": 55.2, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "6 insiders pile into ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122063009/0001209191-22-063009-index.htm", "trade_date": "2022-12-28", "timestamp": "2022-12-28", "mins": 2024084}, {"id": "0001209191-22-060128", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kelly A. Romano", "who_key": "Romano Kelly A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 98700.0, "score": 54.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 7 buying ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122060128/0001209191-22-060128-index.htm", "trade_date": "2022-12-02", "timestamp": "2022-12-02", "mins": 2061524}, {"id": "0001209191-22-057721", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Hans Moebius", "who_key": "MOEBIUS HANS", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 16442.0, "score": 34.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "7 insiders now buying ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122057721/0001209191-22-057721-index.htm", "trade_date": "2022-11-15", "timestamp": "2022-11-15", "mins": 2086004}, {"id": "0001062993-22-015719", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Perceptive Advisors LLC", "who_key": "PERCEPTIVE ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 4100372.3800000004, "score": 62.8, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ATHA draws its 8th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000106299322015719/0001062993-22-015719-index.htm", "trade_date": "2022-06-30", "timestamp": "2022-06-30", "mins": 2284724}, {"id": "0001209191-22-039937", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Hans Moebius", "who_key": "MOEBIUS HANS", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 28800.0, "score": 39.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 8 buying ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122039937/0001209191-22-039937-index.htm", "trade_date": "2022-06-28", "timestamp": "2022-06-28", "mins": 2287604}, {"id": "0001209191-22-022001", "src": "INSIDERS", "ticker": "ATHA", "cik": "1620463", "company": "LeonaBio, Inc.", "company_raw": "Athira Pharma, Inc.", "who": "Kelly A. Romano", "who_key": "Romano Kelly A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 104880.0, "score": 54.3, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "8 insiders pile into ATHA", "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122022001/0001209191-22-022001-index.htm", "trade_date": "2022-03-31", "timestamp": "2022-03-31", "mins": 2415764}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Perceptive Advisors LLC", "who_key": "PERCEPTIVE ADVISORS LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 30563273.04, "sold": 0, "net": 30563273.04, "trades": 4, "top_score": 71.3, "lean": "buying", "history": [{"action": "BUY", "amount": 1462895.16, "date": "2023-12-29", "score": 54.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000106299323023291/0001062993-23-023291-index.htm"}, {"action": "BUY", "amount": 4100372.3800000004, "date": "2022-06-30", "score": 62.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000106299322015719/0001062993-22-015719-index.htm"}, {"action": "BUY", "amount": 6999997.5, "date": "2021-01-25", "score": 62.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000106299321000660/0001062993-21-000660-index.htm"}, {"action": "BUY", "amount": 18000008.0, "date": "2020-09-22", "score": 71.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000089924320025964/0000899243-20-025964-index.htm"}], "latest": {"action": "BUY", "amount": 1462895.16, "date": "2023-12-29", "score": 54.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000106299323023291/0001062993-23-023291-index.htm"}}, {"who": "Joseph Edelman", "who_key": "EDELMAN JOSEPH", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 18000008.0, "sold": 0, "net": 18000008.0, "trades": 1, "top_score": 73.8, "lean": "buying", "history": [{"action": "BUY", "amount": 18000008.0, "date": "2020-09-22", "score": 73.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919120051540/0001209191-20-051540-index.htm"}], "latest": {"action": "BUY", "amount": 18000008.0, "date": "2020-09-22", "score": 73.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919120051540/0001209191-20-051540-index.htm"}}, {"who": "RTW Investments, LP", "who_key": "RTW INVESTMENTS, LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 12750000.0, "sold": 0, "net": 12750000.0, "trades": 1, "top_score": 67.6, "lean": "buying", "history": [{"action": "BUY", "amount": 12750000.0, "date": "2020-09-18", "score": 67.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000149315220018188/0001493152-20-018188-index.htm"}], "latest": {"action": "BUY", "amount": 12750000.0, "date": "2020-09-18", "score": 67.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000149315220018188/0001493152-20-018188-index.htm"}}, {"who": "Kelly A. Romano", "who_key": "Romano Kelly A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 303630.72, "sold": 0, "net": 303630.72, "trades": 3, "top_score": 54.3, "lean": "buying", "history": [{"action": "BUY", "amount": 100050.72, "date": "2024-06-24", "score": 46.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924018177/0001415889-24-018177-index.htm"}, {"action": "BUY", "amount": 98700.0, "date": "2022-12-02", "score": 54.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122060128/0001209191-22-060128-index.htm"}, {"action": "BUY", "amount": 104880.0, "date": "2022-03-31", "score": 54.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122022001/0001209191-22-022001-index.htm"}], "latest": {"action": "BUY", "amount": 100050.72, "date": "2024-06-24", "score": 46.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924018177/0001415889-24-018177-index.htm"}}, {"who": "Andrew Gengos", "who_key": "Gengos Andrew", "role": "See Below", "person_type": "EXEC", "person_label": "Execs", "bought": 243017.22129999998, "sold": 7750.512000000001, "net": 235266.7093, "trades": 5, "top_score": 48.7, "lean": "buying", "history": [{"action": "SELL", "amount": 719.9519999999999, "date": "2024-09-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924022987/0001415889-24-022987-index.htm"}, {"action": "SELL", "amount": 3515.28, "date": "2024-01-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924004149/0001415889-24-004149-index.htm"}, {"action": "BUY", "amount": 51445.007699999995, "date": "2023-06-07", "score": 33.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123035951/0001209191-23-035951-index.htm"}, {"action": "BUY", "amount": 191572.2136, "date": "2023-06-05", "score": 48.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123034887/0001209191-23-034887-index.htm"}, {"action": "SELL", "amount": 3515.28, "date": "2023-01-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919124001153/0001209191-24-001153-index.htm"}], "latest": {"action": "SELL", "amount": 719.9519999999999, "date": "2024-09-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924022987/0001415889-24-022987-index.htm"}}, {"who": "Glenna Mileson", "who_key": "MILESON GLENNA", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 142250.0, "sold": 7031.66, "net": 135218.34, "trades": 2, "top_score": 55.2, "lean": "buying", "history": [{"action": "BUY", "amount": 142250.0, "date": "2022-12-28", "score": 55.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122063009/0001209191-22-063009-index.htm"}, {"action": "SELL", "amount": 7031.66, "date": "2022-06-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122039342/0001209191-22-039342-index.htm"}], "latest": {"action": "BUY", "amount": 142250.0, "date": "2022-12-28", "score": 55.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122063009/0001209191-22-063009-index.htm"}}, {"who": "Mark James Litton", "who_key": "Litton Mark James", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 0, "sold": 91585.8158, "net": -91585.8158, "trades": 7, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 17791.68, "date": "2026-01-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000160483426000002/0001604834-26-000002-index.htm"}, {"action": "SELL", "amount": 7373.6005, "date": "2025-07-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925019069/0001415889-25-019069-index.htm"}, {"action": "SELL", "amount": 14107.6233, "date": "2025-01-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588925000536/0001415889-25-000536-index.htm"}, {"action": "SELL", "amount": 2848.1119999999996, "date": "2024-09-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924022983/0001415889-24-022983-index.htm"}, {"action": "SELL", "amount": 14026.2, "date": "2024-01-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919124001150/0001209191-24-001150-index.htm"}, {"action": "SELL", "amount": 14026.2, "date": "2024-01-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000141588924004153/0001415889-24-004153-index.htm"}, {"action": "SELL", "amount": 21412.399999999998, "date": "2022-06-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919122039340/0001209191-22-039340-index.htm"}], "latest": {"action": "SELL", "amount": 17791.68, "date": "2026-01-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000160483426000002/0001604834-26-000002-index.htm"}}, {"who": "Grant Pickering", "who_key": "PICKERING GRANT", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 60350.0, "sold": 0, "net": 60350.0, "trades": 1, "top_score": 51.5, "lean": "buying", "history": [{"action": "BUY", "amount": 60350.0, "date": "2023-03-30", "score": 51.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123021878/0001209191-23-021878-index.htm"}], "latest": {"action": "BUY", "amount": 60350.0, "date": "2023-03-30", "score": 51.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1620463/000120919123021878/0001209191-23-021878-index.htm"}}], "activity": [], "announcements": [{"form": "SCHEDULE 13D/A", "date": "2026-10-28", "title": "Form SCHEDULE 13D/A", "accession": "0001655566-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-10-26", "title": "Insider transaction", "accession": "0001193125-26-431896", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2026-10-26", "title": "Form SCHEDULE 13D/A", "accession": "0001193125-26-431897", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-22", "title": "Material event", "accession": "0001193125-26-397952", "price_sensitive": true}, {"form": "3", "date": "2026-09-03", "title": "PRIMARY DOCUMENT", "accession": "0002126186-26-000001", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-08-31", "title": "Form SCHEDULE 13D", "accession": "0001655566-26-000003", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-26", "title": "Material event", "accession": "0001193125-26-368288", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-08-25", "title": "Form SCHEDULE 13D/A", "accession": "0001193125-26-365096", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-20", "title": "Form SCHEDULE 13G/A", "accession": "0001636587-26-000069", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "Quarterly report", "accession": "0001193125-26-352243", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-14", "title": "Material event", "accession": "0001193125-26-352208", "price_sensitive": true}, {"form": "4", "date": "2026-07-10", "title": "Insider transaction", "accession": "0001193125-26-300876", "price_sensitive": false}, {"form": "4", "date": "2026-07-09", "title": "Insider transaction", "accession": "0001193125-26-299927", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001843393-26-000006", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001580111-26-000010", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001790314-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001679039-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001722055-26-000005", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001164426-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001225501-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001763316-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-06-24", "title": "Insider transaction", "accession": "0001258693-26-000011", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-23", "title": "Material event", "accession": "0001193125-26-279425", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-05-15", "title": "Form SCHEDULE 13G", "accession": "0001104659-26-062870", "price_sensitive": false}, {"form": "ARS", "date": "2026-05-11", "title": "Form ARS", "accession": "0001193125-26-217029", "price_sensitive": false}], "performance": {"ticker": "ATHA", "has_prices": false, "summary": null, "buys": [{"who": "Romano Kelly A", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 100050.72, "date": "2024-06-24", "score": 46.8, "ref_price": null, "return": null}, {"who": "PERCEPTIVE ADVISORS LLC", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 1462895.16, "date": "2023-12-29", "score": 54.3, "ref_price": null, "return": null}, {"who": "Gengos Andrew", "person_type": "EXEC", "person_label": "Execs", "role": "See Below", "amount": 51445.007699999995, "date": "2023-06-07", "score": 33.2, "ref_price": null, "return": null}, {"who": "Gengos Andrew", "person_type": "EXEC", "person_label": "Execs", "role": "See Below", "amount": 191572.2136, "date": "2023-06-05", "score": 48.7, "ref_price": null, "return": null}, {"who": "PICKERING GRANT", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 60350.0, "date": "2023-03-30", "score": 51.5, "ref_price": null, "return": null}, {"who": "JOHNSON JAMES A", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 12000.0, "date": "2023-03-29", "score": 28.4, "ref_price": null, "return": null}, {"who": "MILESON GLENNA", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 142250.0, "date": "2022-12-28", "score": 55.2, "ref_price": null, "return": null}, {"who": "Hon. Christopher L. Jacobs", "person_type": "POLITICIAN", "person_label": "Politicians", "role": "House \u00b7 NY27", "amount": 1001.0, "date": "2022-12-12", "score": 0.0, "ref_price": null, "return": null}, {"who": "Romano Kelly A", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 98700.0, "date": "2022-12-02", "score": 54.0, "ref_price": null, "return": null}, {"who": "MOEBIUS HANS", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Medical Officer", "amount": 16442.0, "date": "2022-11-15", "score": 34.9, "ref_price": null, "return": null}, {"who": "Hon. Christopher L. Jacobs", "person_type": "POLITICIAN", "person_label": "Politicians", "role": "House \u00b7 NY27", "amount": 1001.0, "date": "2022-07-18", "score": 0.0, "ref_price": null, "return": null}, {"who": "PERCEPTIVE ADVISORS LLC", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 4100372.3800000004, "date": "2022-06-30", "score": 62.8, "ref_price": null, "return": null}, {"who": "MOEBIUS HANS", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Medical Officer", "amount": 28800.0, "date": "2022-06-28", "score": 39.9, "ref_price": null, "return": null}, {"who": "Romano Kelly A", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 104880.0, "date": "2022-03-31", "score": 54.3, "ref_price": null, "return": null}, {"who": "PERCEPTIVE ADVISORS LLC", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 6999997.5, "date": "2021-01-25", "score": 62.6, "ref_price": null, "return": null}, {"who": "PERCEPTIVE ADVISORS LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 18000008.0, "date": "2020-09-22", "score": 71.3, "ref_price": null, "return": null}, {"who": "EDELMAN JOSEPH", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 18000008.0, "date": "2020-09-22", "score": 73.8, "ref_price": null, "return": null}, {"who": "RTW INVESTMENTS, LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 12750000.0, "date": "2020-09-18", "score": 67.6, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}